Literature DB >> 15622970

Type 1 diabetes: molecular, cellular and clinical immunology.

George S Eisenbarth1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15622970

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  17 in total

Review 1.  Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays.

Authors:  Edwin Liu; George S Eisenbarth
Journal:  Clin Immunol       Date:  2007-09-27       Impact factor: 3.969

Review 2.  Targeted immune interventions for type 1 diabetes: not as easy as it looks!

Authors:  Mark R Rigby; Mario R Ehlers
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-08       Impact factor: 3.243

3.  Autoimmune diabetes: ongoing development of immunological intervention strategies targeted directly against autoreactive T cells.

Authors:  Charles Sia
Journal:  Rev Diabet Stud       Date:  2004-05-10

4.  Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells.

Authors:  Thomas Enzler; Silke Gillessen; Michael Dougan; James P Allison; Donna Neuberg; Darryl A Oble; Martin Mihm; Glenn Dranoff
Journal:  Blood       Date:  2007-05-04       Impact factor: 22.113

5.  The Development and Application of HLA Tetramers in the Detection, Characterization and Therapy of Type 1 Diabetes Mellitus.

Authors:  Hsin-Wei Chen; Shih-Jen Liu; Pele Chong; Charles Sia
Journal:  Rev Diabet Stud       Date:  2007-05-10

6.  A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes.

Authors:  Brett Phillips; Karen Nylander; Jo Harnaha; Jennifer Machen; Robert Lakomy; Alexis Styche; Kimberly Gillis; Larry Brown; Debra Lafreniere; Michael Gallo; Janet Knox; Kenneth Hogeland; Massimo Trucco; Nick Giannoukakis
Journal:  Diabetes       Date:  2008-03-03       Impact factor: 9.461

7.  Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes.

Authors:  Natalia Marek-Trzonkowska; Małgorzata Myśliwiec; Dorota Iwaszkiewicz-Grześ; Mateusz Gliwiński; Ilona Derkowska; Magdalena Żalińska; Maciej Zieliński; Marcelina Grabowska; Hanna Zielińska; Karolina Piekarska; Anna Jaźwińska-Curyłło; Radosław Owczuk; Agnieszka Szadkowska; Krystyna Wyka; Piotr Witkowski; Wojciech Młynarski; Przemysława Jarosz-Chobot; Artur Bossowski; Janusz Siebert; Piotr Trzonkowski
Journal:  J Transl Med       Date:  2016-12-01       Impact factor: 5.531

8.  The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human.

Authors:  Éva Korpos; Nadir Kadri; Reinhild Kappelhoff; Jeannine Wegner; Christopher M Overall; Ekkehard Weber; Dan Holmberg; Susanna Cardell; Lydia Sorokin
Journal:  Diabetes       Date:  2012-11-08       Impact factor: 9.461

9.  Murine animal models for preclinical islet transplantation: No model fits all (research purposes).

Authors:  Elisa Cantarelli; Antonio Citro; Simona Marzorati; Raffaella Melzi; Marina Scavini; Lorenzo Piemonti
Journal:  Islets       Date:  2013-03-01       Impact factor: 2.694

Review 10.  Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases.

Authors:  Juan Shi; Shuhong Chi; Jing Xue; Jiali Yang; Feng Li; Xiaoming Liu
Journal:  J Immunol Res       Date:  2016-03-27       Impact factor: 4.818
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.